Heparin is Not Inferior to Bivalirudin in Percutaneous Coronary Intervention--Focusing on the Effect of Glycoprotein IIb/IIIa Inhibitor Use: A Meta-Analysis
In conclusion, when comparing different anticoagulants during PCI, the effect of GPIs should not be underestimated. Heparin as such was found noninferior to Biv.
Source: Angiology - Category: Cardiology Authors: Huang, F.-Y., Huang, B.-T., Peng, Y., Liu, W., Zhao, Z.-G., Wang, P.-J., Zuo, Z.-L., Zhang, C., Liao, Y.-B., Luo, X.-L., Meng, Q.-T., Chen, C., Huang, K.-S., Chai, H., Li, Q., Chen, M., Zhu, Y. Tags: Coronary Heart Disease Source Type: research
More News: Angiomax | Angioplasty | Bleeding | Cardiology | Coronary Angioplasty | Coronary Heart Disease | Heart | Heart Disease | Men | Percutaneous Coronary Intervention